Search Within

Isabelle C Riviere

Formats
  1. Meeting Abstract (139)
  2. Journal Article (93)
  3. Book Section (2)
  4. Conference Paper (2)
  5. Review (2)
  6. Editorial (1)
  7. Research Letter (1)
Groups
  1. Department of Medicine (240)
  2. Hematologic Malignancies, Division of (240)
  3. GSK Faculty (219)
  4. Center for Hematologic Malignancies (216)
  5. Hematologic Malignancies Research (213)
  6. Sloan Kettering Institute Faculty (207)

More Groups

People
  1. Michel Sadelain (200)
  2. Xiuyan Wang (112)
  3. Renier Brentjens (111)
  4. Jae Park (83)
  5. Brigitte Senechal (42)
  6. Kevin Curran (40)

More People

Years
  1. 2025 (2)
  2. 2023 (11)
  3. 2022 (13)
  4. 2021 (13)
  5. 2020 (8)
  6. 2019 (18)

More Years

Publications
  1. Blood (55)
  2. Molecular Therapy (42)
  3. Journal of Clinical Oncology (20)
  4. Human Gene Therapy (10)
  5. Cancer Research (8)
  6. Haematologica (6)

More Publications

Publishers
  1. Nature Publishing Group (67)
  2. American Society of Hematology (56)
  3. American Society of Clinical Oncology (21)
  4. American Association for Cancer Research (15)
  5. Elsevier Inc. (15)
  6. Mary Ann Liebert, Inc (10)

More Publishers

Results (240)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Discovery proteomics for analytes to predict cytokine release syndrome on day of infusion of chimeric antigen receptor (CAR) T cells
    Meeting Abstract

    Lakkaraja, M.; Hosszu, K.; Mcavoy, D.; Mauguen, A.; Purdon, T. J.; Auchincloss, T.; Klein, E.; Khakoo, Y.; Santomasso, B.; Senechal, B.; more...
    Cytotherapy (2022)

    Fulltext@MSK | Save
  • Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy
    Journal Article

    Smith, M.; Dai, A.; Ghilardi, G.; Amelsberg, K. V.; Devlin, S. M.; Pajarillo, R.; Slingerland, J. B.; Beghi, S.; Herrera, P. S.; Giardina, P.; more...
    Nature Medicine (2022)

    Fulltext@MSK | Save
  • HLA-independent T cell receptors for targeting tumors with low antigen density
    Journal Article

    Mansilla-Soto, J.; Eyquem, J.; Haubner, S.; Hamieh, M.; Feucht, J.; Paillon, N.; Zucchetti, A. E.; Li, Z.; Sjöstrand, M.; Lindenbergh, P. L.; more...
    Nature Medicine (2022)

    Fulltext@MSK | Save
  • Lentiviral globin gene therapy with reduced-intensity conditioning in adults with β-thalassemia: A phase 1 trial
    Journal Article

    Boulad, F.; Maggio, A.; Wang, X.; Moi, P.; Acuto, S.; Kogel, F.; Takpradit, C.; Prockop, S.; Mansilla-Soto, J.; Cabriolu, A.; more...
    Nature Medicine (2022)

    Fulltext@MSK | Save
  • CD19-directed chimeric antigen receptor T cell therapy in Waldenström macroglobulinemia: A preclinical model and initial clinical experience
    Journal Article

    Palomba, M. L.; Qualls, D.; Monette, S.; Sethi, S.; Dogan, A.; Roshal, M.; Senechal, B.; Wang, X.; Rivière, I.; Sadelain, M.; more...
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Manufacturing of CAR-T cells: The assembly line
    Journal Article

    Wang, X.; Rivière, I.
    Cancer Drug Discovery and Development (2022)

    Fulltext@MSK | Save
  • Clinical manufacture of FT819: Use of a clonal multiplexed-engineered master induced pluripotent stem cell line to mass produce off-the-shelf CAR T-cell therapy
    Meeting Abstract

    Yuan, X.; Clarke, R.; Lai, Y. S.; Chang, C. W.; Yang, B. H.; Hsia, G.; Abujarour, R.; Lee, T.; van der Stegen, S.; Shaked, H.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • The intestinal microbiota correlates with response and toxicity after CAR T cell therapy in patients with B-cell malignancies
    Meeting Abstract

    Smith, M.; Dai, A.; Ghilardi, G.; Amelsberg, K.; Devlin, S. M.; Pajarillo, R.; Slingerland, J. B.; Beghi, S.; Herrera, P. S.; Giardina, P. A.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Phase I first-in-class trial of MCARH109, a G protein coupled receptor class C group 5 member D (GPRC5D) targeted CAR T cell therapy in patients with relapsed or refractory multiple myeloma
    Meeting Abstract

    Mailankody, S.; Diamonte, C.; Fitzgerald, L.; Kane, P.; Wang, X.; Sikder, D. S.; Senechal, B.; Bermudez, V. P.; Frias, D.; Morgan, J.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Promoting functional persistence in solid tumor CAR T-cell therapy: Mesothelin-targeted CAR (M28z1XXPD1DNR) with T-cell intrinsic PD1 dominant negative receptor
    Meeting Abstract

    Adusumilli, P. S.; Amador, A. M.; Chintala, N.; Hou, Z.; Offin, M.; Pineda, J.; Senechal, B.; Quach, H. T.; Bellis, R.; Banerjee, S.; more...
    Annals of Oncology (2021)

    Fulltext@MSK | Save